Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11 and is potentially preventable through vaccination. This study estimated the incidence of juvenile-onset RRP before the implementation of the national HPV vaccination program in Korea. METHODS: We conducted a cohort study using claims data provided by a mandatory insurance program to estimate the incidence of RRP and associated healthcare use. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits during which they received the International Classification of Diseases, 10th revision code for benign neoplasms of the larynx (D14.1). RESULTS: During 2002-2014, 123 children (74 boys and 49 girls) were diagnosed with RRP. The patients had a mean of 6.5 person-years of follow-up. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years (mean, 4.3). Thirty-six (29.3%) patients underwent surgery, including 23 patients (18.7%) who underwent 2 or more surgical procedures. Severe disease, measured by more frequent surgical procedures and shorter time intervals between consecutive operations, was associated with a younger age at diagnosis. CONCLUSIONS: The estimated incidence of juvenile-onset RRP in Korea was similar to that reported in other countries. The RRP burden should continue to be monitored using National Health Insurance Service claims data.
Abstract
OBJECTIVES: Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11 and is potentially preventable through vaccination. This study estimated the incidence of juvenile-onset RRP before the implementation of the national HPV vaccination program in Korea. METHODS: We conducted a cohort study using claims data provided by a mandatory insurance program to estimate the incidence of RRP and associated healthcare use. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits during which they received the International Classification of Diseases, 10th revision code for benign neoplasms of the larynx (D14.1). RESULTS: During 2002-2014, 123 children (74 boys and 49 girls) were diagnosed with RRP. The patients had a mean of 6.5 person-years of follow-up. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years (mean, 4.3). Thirty-six (29.3%) patients underwent surgery, including 23 patients (18.7%) who underwent 2 or more surgical procedures. Severe disease, measured by more frequent surgical procedures and shorter time intervals between consecutive operations, was associated with a younger age at diagnosis. CONCLUSIONS: The estimated incidence of juvenile-onset RRP in Korea was similar to that reported in other countries. The RRP burden should continue to be monitored using National Health Insurance Service claims data.
참고문헌 (29)
- Carifi M, "Recurrent respiratory papillomatosis : current and future perspectives", Ther Clin Risk Manag, 11, pp.731~738 (2015)
- Gillison ML, "Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis", Vaccine, 30(Suppl 5), pp.F34~F54 (2012)
- Omland T, "Recurrent respiratory papillomatosis : HPV genotypes and risk of high-grade laryngeal neoplasia", PLoS One, 9, pp.e99114~ (2014)
- Ağgünlü L, "Recurrent respiratory papillomatosis with lung involvement", Diagn Interv Radiol, 15, pp.93~95 (2009)
- Chang CH, "Virtual bronchoscopy for diagnosis of recurrent respiratory papillomatosis", J Formos Med Assoc, 105, pp.508~511 (2006)
- Marchiori E, "Laryngotracheobronchial papillomatosis : findings on computed tomography scans of the chest", J Bras Pneumol, 34, pp.1084~1089 (2008)
- Fusconi M, "Recurrent respiratory papillomatosis by HPV : review of the literature and update on the use of cidofovir", Acta Otorhinolaryngol Ital, 34, pp.375~381 (2014)
- Armstrong LR, "Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle", Clin Infect Dis, 31, pp.107~109 (2000)
- Campisi P, "The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database", Laryngoscope, 120, pp.1233~1245 (2010)
- Marsico M, "Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States", Sex Transm Dis, 41, pp.300~305 (2014)
- Novakovic D, "Juvenile recurrent respiratory papillomatosis : 10-year audit and Australian prevalence estimates", Laryngoscope, 126, pp.2827~2832 (2016)
- Omland T, "Epidemiological aspects of recurrent respiratory papillomatosis : a population-based study", Laryngoscope, 122, pp.1595~1599 (2012)
- Seedat RY, "The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho", Int J Pediatr Otorhinolaryngol, 78, pp.2113~2115 (2014)
- Seedat RY, "Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis-a South African perspective", Clin Otolaryngol, 43, pp.533~537 (2018)
- Niyibizi J, "Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis : a systematic review", Int J Pediatr Otorhinolaryngol, 78, pp.186~197 (2014)
- Fortes HR, "Recurrent respiratory papillomatosis : a state-of-the-art review", Respir Med, 126, pp.116~121 (2017)
- Reeves WC, "National registry for juvenile-onset recurrent respiratory papillomatosis", Arch Otolaryngol Head Neck Surg, 129, pp.976~982 (2003)
- Venkatesan NN, "Recurrent respiratory papillomatosis", Otolaryngol Clin North Am, 45, pp.671~694 (2012)
- "Guidelines for the National Immunization Program 2017"[URL]
- National Health Insurance Service, "National health insurance statistical yearbook" (2016), National Health Insurance Service
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- "Population statistics based on resident registration"[URL]
- Buchinsky FJ, "Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis", PLoS One, 14, pp.e0216697~ (2019)
- Silverberg MJ, "Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis", Obstet Gynecol, 101, pp.645~652 (2003)
- Katsenos S, "Recurrent respiratory papillomatosis : a rare chronic disease, difficult to treat, with potential to lung cancer transformation : apropos of two cases and a brief literature review", Case Rep Oncol, 4, pp.162~171 (2011)
- "Information on pharmaceutical products -- human papillomavirus vaccine"[URL]
- "For girls born in 2006-2007, don’t forget to get ‘human papillomavirus (HPV)vaccine’ during summer vacation"[URL]
- Novakovic D, "A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program", J Infect Dis, 217, pp.208~212 (2018)
- Donne AJ, "Prevalence and management of recurrent respiratory papillomatosis(RRP)in the UK : cross-sectional study", Clin Otolaryngol, 42, pp.86~91 (2017)